This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Gregory Schaaf: Innovator in Pharmaceutical Compounds
Introduction
Gregory Schaaf is a distinguished inventor based in Durham, North Carolina, renowned for his contributions to the pharmaceutical industry. With a focus on innovative chemical compounds, Schaaf has made significant advancements in the field of medicinal chemistry.
Latest Patents
Schaaf holds a patent for "Benzene sulfonamide thiazole and oxazole compounds." This invention encompasses thiazole sulfonamide and oxazole sulfonamide compounds along with their compositions. The patent also details processes for preparing these compounds and methods for their use as pharmaceutical agents, showcasing his commitment to developing effective medical solutions.
Career Highlights
Gregory Schaaf is a valuable member of GlaxoSmithKline LLC, a global leader in pharmaceuticals. His work at this prestigious company underscores his role in pioneering research that contributes to health advancements.
Collaborations
Throughout his career, Schaaf has collaborated with esteemed colleagues such as George Adjabeng and Jerry Leroy Adams. These professional relationships demonstrate the collaborative spirit that drives innovation within the pharmaceutical industry.
Conclusion
Gregory Schaaf's inventive work, particularly his patent on benzene sulfonamide thiazole and oxazole compounds, marks him as a key player within his field. His ongoing contributions at GlaxoSmithKline LLC continue to influence the development of new therapeutic agents, reflecting the importance of innovation in enhancing health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile